CTRI Number |
CTRI/2021/09/036573 [Registered on: 16/09/2021] Trial Registered Prospectively |
Last Modified On: |
08/09/2021 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
A clinical trial To study the effect of Ayurvedic interventions on improving under-five children in Devbhoomi Dwarka district of Gujarat, India. |
Scientific Title of Study
|
Documenting impact of Ayurvedic intervention to improve the nutritional status of under five children and adolescents in Devbhoomi Dwarka distric, Gujarat, India |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Vd Falgun Patel |
Designation |
I/c deputy Director (Training & Reasearch) |
Affiliation |
Govt. of Gujarat |
Address |
Directorate Ayush, Second floor,Block-1, Jivraj Mehta Bhavan,
Gandhinagar
Gandhinagar GUJARAT 382010 India |
Phone |
|
Fax |
|
Email |
ddayushtraining@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Vd Shital Bhagiya |
Designation |
Lecturer |
Affiliation |
Govt. of Gujarat |
Address |
Department of Panchakarma,
State model Ayurveda College, Kolavada
Gandhinagar GUJARAT 382028 India |
Phone |
|
Fax |
|
Email |
shital1811@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Jimeet Soni |
Designation |
Research Associate |
Affiliation |
Indian Institute of Public health |
Address |
Indian Institute of Public health Gandhinagar, opp- Air force head quarter, palaj road, lekavada cross road, Gandhinagr
Gandhinagar GUJARAT 382042 India |
Phone |
|
Fax |
|
Email |
jimeetsoni9@gmail.com |
|
Source of Monetary or Material Support
|
Govt. Ayurved pharmacy Rajpipla, Vadiya Palace Campus, Rajpipla , Gujarat |
|
Primary Sponsor
|
Name |
Dr Bhavna Patel Director Ayush |
Address |
Directorate Ayush, Second Floor, Block-1 , Jivraj Mehta Bhavan,
Gandhinagar. |
Type of Sponsor |
Other [Govt. of Gujarat] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 2 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Deepak Saxena |
Bhanvad |
Indian Institute of Public
health Gandhinagar, opp- Air force head quarter,
palaj road, lekavada cross road, Gandhinagr. Jamnagar GUJARAT |
9327396717
ddeepak72@iiphg.com |
Dr Deepak Saxena |
OKHA MANDAL BLOCK |
Indian Institute of Public
health Gandhinagar, opp- Air force head quarter,
palaj road, lekavada cross road, Gandhinagr. Jamnagar GUJARAT |
9327396717
ddeepak72@iiphg.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Indian Institute of Public Health |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:E649||Sequelae of unspecified nutritional deficiency. Ayurveda Condition: PANDUROGAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Other than Classical | | (1) Medicine Name: Shishu Bheshaj Granules, Reference: NA, Route: Oral, Dosage Form: Khanda/Granules, Dose: 15(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 180 Days, anupAna/sahapAna: Yes(details: Milk), Additional Information: |
|
|
Inclusion Criteria
|
Age From |
0.00 Day(s) |
Age To |
5.00 Year(s) |
Gender |
Both |
Details |
Parents willing to give consent
Child with no morbid condition
|
|
ExclusionCriteria |
Details |
Parents not giving consent
Child having any morbid condition
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Centralized |
Blinding/Masking
|
Participant Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Morbidity due to malnutrition disease
Weight gain
|
Baseline, 3 months, 6 months
|
|
Secondary Outcome
|
Outcome |
TimePoints |
Improvement in stunting and malnutrition status time
Improvement in diet and hunger
|
6 month |
|
Target Sample Size
|
Total Sample Size="180" Sample Size from India="180"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
17/09/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NA |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
The proposed study will be done in below mentioned phase. Phase 1: The first phase will be preparatory one, includes round tables of experts of Ayurveda, Nutritionists and Epidemiologists to identify available Ayurveda intervention. This phase will also include identification of taluka with a higher prevalence of taluka stratified as per geographical boundaries. Children with severe malnutrition or severely underweight will be eligible for Ayurveda intervention. Phase 2: Intervention phase Second phase will involve baseline, intervention and midterm evaluation. The intervention will be conducted as a pre-post trial. The intervention will be executed through AYUSH medical officer posted at Primary Health Centre or at Ayurveda dispensaries in the supervision of D.A.O of concerned dist. Baseline and End line assessment of the nutritional status will also be done. Process documentation of the intervention and provision of midterm correction if needed. This process will also involve giving basic information to the participants about the malnutrition and also compliance of the intervention and reporting of side effects if any. |